Tags » Aurobindo Pharma

FDA approves India's Aurobindo's generic version of Alcon's Patanol

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% which makes the product is ready for launch. 106 more words

News

AN IMPROVED PROCESS FOR THE PREPARATION OF DOLUTEGRAVIR

Aurobindo Pharma MD and CEO N. Govindarajan at a company research centre. “It is purely driven by the need to get more into areas where there is scope for better profit margins, 1,806 more words

Top 20 Japanese pharma cos eyeing India drug majors for acquisitions

Top 20 Japanese companies like Takeda, Astellas, Mitsui, Mitsubishi Pharma, Dainippon Sumitomo etc. are seriously scouting for various business opportunities in Indian drug market. 434 more words

Aurous Posts

India remains the largest supplier country, says UNICEF

UNICEF recently released its Supply Annual Report for 2012: India is the Largest Supplier. The Report is an yearly assessment of the UNICEF supply programme which provides women and children with an equitable access to life-saving supplies. 904 more words

United States

Wockhardt Too a Part of FDA Toxic Capsule

Source: Economic Times

May24,2013

Wockhardt has been banned from exporting products from its Aurangabad factory to the US after that country’s food and drug regulator issued an ‘import alert’, citing concerns over the quality of drugs manufactured at the plant.  455 more words

Generics

APOTEX INC RECEIVES WARNING LETTER FOR MULTIPLE CANADIAN SITES (2/21/13) PART II

FDA INVESTIGATOR FINDS INACCURATE REPORTING OF MICROBIOLOGICAL DATA

The FDA, during August and October 2012 inspected two Apotex, Inc. sites.  This Blog only discusses the facilities located at 150 Signet Drive, Toronto, Canada.  505 more words

FDA Compliance